PL2550963T3 - Estry kwasu amidooksymokarboksylowego pentamidyny jako proleki i ich zastosowanie jako leki - Google Patents
Estry kwasu amidooksymokarboksylowego pentamidyny jako proleki i ich zastosowanie jako lekiInfo
- Publication number
- PL2550963T3 PL2550963T3 PL11175252T PL11175252T PL2550963T3 PL 2550963 T3 PL2550963 T3 PL 2550963T3 PL 11175252 T PL11175252 T PL 11175252T PL 11175252 T PL11175252 T PL 11175252T PL 2550963 T3 PL2550963 T3 PL 2550963T3
- Authority
- PL
- Poland
- Prior art keywords
- pentamidine
- prodrugs
- medicament
- carboxylic acid
- acid esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11175252.3A EP2550963B1 (de) | 2011-07-25 | 2011-07-25 | Pentamidin-Amidoximsäureesters als Prodrugs und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2550963T3 true PL2550963T3 (pl) | 2017-08-31 |
Family
ID=46514404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11175252T PL2550963T3 (pl) | 2011-07-25 | 2011-07-25 | Estry kwasu amidooksymokarboksylowego pentamidyny jako proleki i ich zastosowanie jako leki |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20130085180A1 (https=) |
| EP (1) | EP2550963B1 (https=) |
| JP (2) | JP2014529579A (https=) |
| KR (1) | KR20140097108A (https=) |
| CN (1) | CN103874491A (https=) |
| AU (1) | AU2012288968B2 (https=) |
| BR (1) | BR112014001787A2 (https=) |
| CA (1) | CA2842355A1 (https=) |
| DK (1) | DK2550963T3 (https=) |
| ES (1) | ES2610652T3 (https=) |
| HR (1) | HRP20170013T1 (https=) |
| HU (1) | HUE030245T2 (https=) |
| LT (1) | LT2550963T (https=) |
| PL (1) | PL2550963T3 (https=) |
| PT (1) | PT2550963T (https=) |
| RS (1) | RS55557B1 (https=) |
| RU (1) | RU2608388C2 (https=) |
| SI (1) | SI2550963T1 (https=) |
| WO (1) | WO2013014059A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015014836A2 (pt) | 2012-12-21 | 2017-07-11 | Verlyx Pharma Inc | método para tratamento alvo de uma ou mais condições do fígado, e, uso oral de uma quantidade terapeuticamente eficaz de pelo menos um análogo de diamidina ou um sal farmaceuticamente aceitável da mesma |
| EP3687514A4 (en) | 2017-09-27 | 2021-06-30 | Ohio State Innovation Foundation | METHODS AND COMPOSITIONS FOR INHIBITING STAT3 |
| US12594265B2 (en) | 2017-09-27 | 2026-04-07 | Ohio State Innovation Foundation | Methods and compositions for inhibition of STAT3 |
| US10835581B2 (en) | 2017-11-28 | 2020-11-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Method of treating insulin resistance |
| US12398105B2 (en) * | 2018-12-20 | 2025-08-26 | Auransa Inc. | Analogues of pentamidine and uses therefor |
| EP4688745A2 (en) * | 2023-04-07 | 2026-02-11 | Auransa Inc. | Pentamidine analogue polymorphs, formulations, and methods thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4321444A1 (de) * | 1993-06-28 | 1995-01-05 | Bernd Prof Dr Clement | Pharmazeutische Zubereitung |
| US5723495A (en) * | 1995-11-16 | 1998-03-03 | The University Of North Carolina At Chapel Hill | Benzamidoxime prodrugs as antipneumocystic agents |
| US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
| DE102008007381A1 (de) * | 2008-02-01 | 2009-08-13 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten |
-
2011
- 2011-07-25 EP EP11175252.3A patent/EP2550963B1/de not_active Not-in-force
- 2011-07-25 PL PL11175252T patent/PL2550963T3/pl unknown
- 2011-07-25 PT PT111752523T patent/PT2550963T/pt unknown
- 2011-07-25 HU HUE11175252A patent/HUE030245T2/en unknown
- 2011-07-25 SI SI201131053A patent/SI2550963T1/sl unknown
- 2011-07-25 DK DK11175252.3T patent/DK2550963T3/en active
- 2011-07-25 ES ES11175252.3T patent/ES2610652T3/es active Active
- 2011-07-25 LT LTEP11175252.3T patent/LT2550963T/lt unknown
- 2011-07-25 RS RS20170002A patent/RS55557B1/sr unknown
-
2012
- 2012-07-19 CA CA2842355A patent/CA2842355A1/en not_active Abandoned
- 2012-07-19 AU AU2012288968A patent/AU2012288968B2/en not_active Ceased
- 2012-07-19 WO PCT/EP2012/064171 patent/WO2013014059A1/de not_active Ceased
- 2012-07-19 RU RU2014106867A patent/RU2608388C2/ru not_active IP Right Cessation
- 2012-07-19 KR KR1020147004770A patent/KR20140097108A/ko not_active Withdrawn
- 2012-07-19 BR BR112014001787A patent/BR112014001787A2/pt not_active IP Right Cessation
- 2012-07-19 CN CN201280037041.7A patent/CN103874491A/zh active Pending
- 2012-07-19 JP JP2014522041A patent/JP2014529579A/ja not_active Withdrawn
- 2012-10-05 US US13/554,536 patent/US20130085180A1/en not_active Abandoned
-
2016
- 2016-09-06 JP JP2016173855A patent/JP2017039727A/ja not_active Withdrawn
-
2017
- 2017-01-05 HR HRP20170013TT patent/HRP20170013T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20170013T1 (hr) | 2017-03-10 |
| PT2550963T (pt) | 2017-01-19 |
| AU2012288968B2 (en) | 2017-01-05 |
| JP2014529579A (ja) | 2014-11-13 |
| LT2550963T (lt) | 2017-02-27 |
| DK2550963T3 (en) | 2017-01-30 |
| RU2608388C2 (ru) | 2017-01-18 |
| RU2014106867A (ru) | 2015-08-27 |
| JP2017039727A (ja) | 2017-02-23 |
| KR20140097108A (ko) | 2014-08-06 |
| BR112014001787A2 (pt) | 2017-02-21 |
| EP2550963A1 (de) | 2013-01-30 |
| SI2550963T1 (sl) | 2017-05-31 |
| EP2550963B1 (de) | 2016-10-12 |
| RS55557B1 (sr) | 2017-05-31 |
| AU2012288968A1 (en) | 2014-02-13 |
| HUE030245T2 (en) | 2017-04-28 |
| ES2610652T3 (es) | 2017-04-28 |
| CN103874491A (zh) | 2014-06-18 |
| US20130085180A1 (en) | 2013-04-04 |
| WO2013014059A1 (de) | 2013-01-31 |
| CA2842355A1 (en) | 2013-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2899182T3 (pl) | Aryloalkilowe estry 4-aminopikolinianów oraz ich zastosowanie jako herbicydy | |
| SMT202100220T1 (it) | Metodi per ridurre il rischio di un evento cardiovascolare in un soggetto in terapia con statine usando l'estere etilico dell'acido eicosapentaenoico | |
| ZA201105612B (en) | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia | |
| EP2788003A4 (en) | PHOSPHATESTER OF NORIBOGAIN | |
| ZA201402803B (en) | Antimicrobial mixture of aldehydes, organic acids and arganic acid esters | |
| IL227644A0 (en) | 6-amino-2-conversion-5-vinylsilylpyrimidine-4-carboxyl acids and esters and 4-amino-6-conversion-3-vinylsilylpyrimidine-2-carboxyl acids and esters as herbicides | |
| IL233413A0 (en) | Methods for producing fincol esters of 4-chloro-2-fluoro-3-converted-phenylboronic acid and methods for using them | |
| PL2870134T3 (pl) | Zastosowanie estrów kwasów karboksylowych jako smarów | |
| EP2614152A4 (en) | CATALYTIC DEHYDRATION OF MILKY ACID AND MILKIC ACID ESTERS | |
| EP2660235A4 (en) | METHOD FOR THE PRODUCTION OF ACRYLIC ACID AND / OR ESTER THEREOF AND POLYMER FROM ACRYLIC ACID AND / OR ESTER THEREOF | |
| EP2788356A4 (en) | SULFATESTER FROM NORIBOGAIN | |
| ZA201401746B (en) | Use and agrochemical composition of carboxylic acid dibutylamides | |
| AP3787A (en) | New form of administration of enkephalinase inhibitor | |
| EP2513174A4 (en) | EMULSION POLYMERIZATION OF ITACONIC ACID ESTERS | |
| ZA201400087B (en) | Fluorination of acrylate esters and derivatives | |
| ZA201303357B (en) | Ketocarboxylic acids, ketocarboxylic esters, methods of manufacture and uses thereof | |
| SG11201501693TA (en) | Alcohol-mediated esterification of carboxylic acids with carbonates | |
| LT2550963T (lt) | Pentamidino-amidoksimo karboksirūgšties esteriai, kaip provaistai, ir jų naudojimas kaip vaistų | |
| PL2550966T3 (pl) | Estry kwasu amidooksymokarboksylowego dabigatranu jako proleki i ich zastosowanie jako lek | |
| IL233132A (en) | Process for Preparation of Esters of 5-Fluoro-2-Methyl-3-Quinoline-2-Illmethylindole-1-Ill-Acetic Acid | |
| SG2014012587A (en) | Process for preparation of methacrylic acid and methacrylic acid esters | |
| SG2014012637A (en) | Process for preparation of methacrylic acid and methacrylic acid ester | |
| SG2014012561A (en) | Process for preparation of methacrylic acid and methacrylic acid esters | |
| ZA201307230B (en) | Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma-glutamyl-l-tryptophan |